Validation of the Norma Latina Neuropsychological Assessment Battery in Patients with Alzheimer’s Disease in Mexico

[EN] To our knowledge, this is the first study reported in the literature that has validated the Norma Latina Battery in a population of people with Alzheimer's disease (AD) in Mexico. The objective of the study was to determine the discriminant validity of the Norma Latina Battery in a group o...

Descripción completa

Detalles Bibliográficos
Autores: Núñez Fernández, Silvia, Rivera, Diego, Arroyo Anlló, Eva María, Ortiz Jiménez, Xóchitl Angélica, Camino-Pontes, Borja, Salinas Martínez, Ricardo, Arango Lasprilla, Juan Carlos
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Universidad de Salamanca (USAL)
Repositorio:GREDOS. Repositorio Institucional de la Universidad de Salamanca
OAI Identifier:oai:gredos.usal.es:10366/155016
Acceso en línea:http://hdl.handle.net/10366/155016
Access Level:acceso abierto
Palabra clave:Alzheimer’s disease
Latin America
Mexico
Cognitive problems
Neuropsychological assessment
Neuropsychology
3205.07 Neurología
neuropsicología
Descripción
Sumario:[EN] To our knowledge, this is the first study reported in the literature that has validated the Norma Latina Battery in a population of people with Alzheimer's disease (AD) in Mexico. The objective of the study was to determine the discriminant validity of the Norma Latina Battery in a group of Mexican individuals with AD and a group of heathy controls (HC). The Norma Latina Battery was administered to 234 Mexican participants (117 HC and 117 individuals with AD). Results show that: (1) the Norma Latina Battery has high discriminative capacity between groups in all domains; (2) participants with AD presented worse scores in each of the cognitive domains compared to the HC and a greater number of low scores in each of the established thresholds or cut-off points; and finally, (3) the Norma Latina Battery had optimal sensitivity and specificity, especially when a set was observed ≥5 scores below the 10th percentile or ≥4 scores below the 5th percentile. In conclusion, it is recommended that both clinicians and researchers use this battery in the evaluation of Mexican people with AD to better understand the prognosis of the disease and its subsequent treatment.

Similares en LA Referencia